
Avaspray
Square Pharmaceuticals PLC.
Fluticasone Furoate is a synthetic trifluorinated corticosteroid used topically (intranasally and by oral inhalation) for its potent local anti-inflammatory effect.
Fluticasone Furoate is a synthetic trifluorinated corticosteroid used topically (intranasally and by oral inhalation) for its potent local anti-inflammatory effect. Its approved uses differ by dosage form and are classified below by strength of evidence.
Fluticasone Furoate inhalation powder is a maintenance medicine only and is not indicated for the relief of acute bronchospasm or acute asthma exacerbations; a separate fast-acting rescue inhaler must be used for acute symptoms.
Dosing of Fluticasone Furoate depends on the indication, dosage form, and patient age. It should be used regularly, not on an as-needed basis, for full benefit.
| Indication / Form | Age Group | Recommended Dose |
|---|---|---|
| Allergic rhinitis (nasal spray, 27.5 mcg/spray) | Adults & adolescents ≥12 years | 2 sprays (55 mcg total) in each nostril once daily; may reduce to 1 spray per nostril once daily after symptoms are controlled |
| Children 2–11 years | 1 spray in each nostril once daily; may increase to 2 sprays per nostril once daily if response is inadequate, then reduce once controlled | |
| Children <2 years | Safety and efficacy not established | |
| Asthma maintenance (oral inhalation powder) | Adults & adolescents ≥12 years | 100 mcg once daily; may increase to 200 mcg once daily if inadequately controlled (maximum 200 mcg/day) |
| Children 5–11 years | 50 mcg once daily | |
| Children <5 years | Safety and efficacy not established |
The inhalation form of Fluticasone Furoate must be taken with a separate fast-acting rescue bronchodilator available for acute symptoms; it is not a substitute for a rescue inhaler. See Administration for device-specific technique.
| Formulation | Common Side Effects | Less Common / Serious |
|---|---|---|
| Nasal spray | Epistaxis (nosebleed), nasal irritation/ulceration, headache, nasopharyngitis, back pain | Nasal septal perforation, impaired wound healing, vision changes, signs of systemic corticosteroid effect (rare at recommended doses) |
| Inhalation powder | Nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal (oral) candidiasis, hoarseness/dysphonia, bronchitis | Paradoxical bronchospasm, pneumonia (in COPD patients using combination products), adrenal suppression, decreased bone mineral density, growth suppression in children, cataracts, glaucoma |
Rinsing the mouth after each inhaled dose of Fluticasone Furoate reduces the risk of oral candidiasis and hoarseness. Patients should seek prompt medical advice for vision changes, signs of infection, or unusual bruising/weakness.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.